Krysiak Robert, Okopień Bogusław, Herman Zbigniew Stanisław
Slaska Akademia Medyczna w Katowicach, Katedra Farmakologii, Zakład Farmakologii Klinicznej.
Pol Merkur Lekarski. 2006 Jul;21(121):73-9.
Technological advance of the recent years has contributed to the development of the situation during which clinically inapparent masses are discovered in endocrine organs by high-resolution radiological imaging procedures that have been performed for other reasons. Most of these lesions, frequently referred to as incidentalomas, are clinically insignificant benign and hormonally inactive adenomas that neither pose a risk to a patient's health nor warrant the risks of further diagnosis and treatment. One of the greatest challenges of modern endocrinology is to distinguish the vast majority of clinically insignificant changes from other masses requiring further management such as hormone-secreting tumours and malignant lesions. Over the years a myriad of the diagnostic and therapeutic approaches has been recommended and presently there are still no uniform guidelines. The purpose of his article is to give an overview on the recent advances in diagnosis and management of pituitary and adrenal incidentalomas. We provide the reader with practical recommendations and underline areas in which further studies are required.
近年来的技术进步推动了一种情况的发展,即因其他原因进行的高分辨率放射成像检查发现了内分泌器官中临床上不明显的肿块。这些病变大多常被称为偶发瘤,是临床上无意义的良性且无激素活性的腺瘤,既不会对患者健康构成风险,也无需承担进一步诊断和治疗的风险。现代内分泌学面临的最大挑战之一是将绝大多数临床上无意义的变化与其他需要进一步处理的肿块区分开来,如分泌激素的肿瘤和恶性病变。多年来,人们推荐了无数的诊断和治疗方法,目前仍然没有统一的指南。本文的目的是概述垂体和肾上腺偶发瘤诊断和管理的最新进展。我们为读者提供实用建议,并强调需要进一步研究的领域。